EyeCRO are Experts in preclinical efficacy studies in ophthalmic retinopathy, pharmacokinetics, both in vivo and in vitro for clinical and precise formulation services and trial batteries. EyeCRO is a preclinical ophthalmic research organization focused on studies in retina preclinical efficacy, oxygen-induced retinopathy, and ophthalmic pharmacokinetics for clinical and precise formulation services and trial batteries. EyeCRO is a preclinical ophthalmic research organization focused on studies in Laser CNV, Retina preclinical efficacy, and Ophthalmic toxicology for clinical and precise formulation services.

Web developed by Josh Bolinger website design

The Global Leader in Preclinical Ophthalmic Research

MiDROPS™

The Microemulsion Drug Ocular Penetration System (MiDROPS™) is a transformative technology for the development of eyedrop formulations.  This patented platform allows for the preparation and delivery of lipophilic agents to tissues in both the front and back of the eye.  MiDROPS™ are prepared using materials already approved by the US Food and Drug Administration for use in ophthalmic products, and by nature are intrinsically thermo-stable.

 

In-Vivo

EyeCRO provides numerous in-vivo research models to enable directed and meaningful preclinical drug discovery and development programs. EyeCRO also has extensive experience in various routes of administration and can customize studies depending on your needs. One of the main advantages in working with EyeCRO is our ability to be flexible.

Retinal Remodeling And Metabolic Alterations in Human AMD

Age-related macular degeneration (AMD) is a progressive retinal degeneration resulting in central … Read More

Avalanche Biotechnologies Closes Transaction With Annapurna Therapeutics

Avalanche Biotechnologies, Inc. (AAVL) today announced the closing of the previously announced … Read More

EyeCRO data to be presented at ARVO 2016 in Seattle

Read More

More News

Saturday, May 28th, 2016 at 8:39am
Pharmacological Amelioration of Cone Survival and Vision in a Mouse Model for Leber Congenital Amaurosis https://t.co/yUbqohrLKR
Friday, May 27th, 2016 at 3:05pm
NeuMedics Invited to Speak at the Life Science Innovation Northwest 2016 in Seattle https://t.co/ULnDLpyPP0 #MiDROPS #cureblindness
Friday, May 27th, 2016 at 8:34am
RT @jaheedkhan: Did you know that the #eye is the second most complex part of our body? More eye facts here: https://t.co/NaCwPFtPTA https:… EyeCRO photo
Ophthalmic Contract Research